Manipulation of a quasi-natural cell block for high-efficiency transplantation of adherent somatic cells

por Chung, H.J., Hassan, M.M., Park, J.O., Kim, H.J., Hong, S.T.
Publicado 2015

Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum

por Yi, J H, Lee, J, Lee, J, Park, S H, Park, J O, Yim, D-S, Park, Y S, Lim, H Y, Kang, W K
Publicado 2012

MAP2K1 Mutation in Colorectal Cancer Patients: Therapeutic Challenge Using Patient-Derived Tumor Cell Lines

por Kim, J. E., Kim, K.K., Kim, S. Y., Lee, J., Park, S. H., Park, J. O., Park, Y. S., Lim, H. Y., Kang, W. K., Kim, S. T.
Publicado 2017

Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours

por Ahn, H K, Choi, J Y, Kim, K-M, Kim, H, Choi, S-H, Park, S H, Park, J O, Lim, H Y, Kang, W K, Lee, J, Park, Y S
Publicado 2013

Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer

por Kim, S T, Kang, W K, Kang, J H, Park, K W, Lee, J, Lee, S-H, Park, J O, Kim, K, Kim, W S, Jung, C W, Park, Y S, Im, Y-H, Park, K
Publicado 2005

Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer

por Lee, S-H, Kang, W K, Park, J, Kim, H Y, Kim, J H, Lee, S I, Park, J O, Kim, K, Jung, C W, Park, Y S, Im, Y-H, Lee, M H, Park, K
Publicado 2004

Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients

por Koivunen, J P, Kim, J, Lee, J, Rogers, A M, Park, J O, Zhao, X, Naoki, K, Okamoto, I, Nakagawa, K, Yeap, B Y, Meyerson, M, Wong, K-K, Richards, W G, Sugarbaker, D J, Johnson, B E, Jänne, P A
Publicado 2008

A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer

por Lim, S H, Kim, T W, Hong, Y S, Han, S-W, Lee, K-H, Kang, H J, Hwang, I G, Lee, J Y, Kim, H S, Kim, S T, Lee, J, Park, J O, Park, S H, Park, Y S, Lim, H Y, Jung, S-H, Kang, W K
Publicado 2015

Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib

por Hammel, P, Kindler, H L, Reni, M, Van Cutsem, E, Macarulla, T, Hall, M J, Park, J O, Hochhauser, D, Arnold, D, Oh, D -Y, Reinacher-Schick, A, Tortora, G, Algül, H, O’Reilly, E M, McGuinness, D, Cui, K Y, Joo, S, Yoo, H K, Patel, N, Golan, T
Publicado 2019

Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective stud...

por Park, H.S., Kang, B., Chon, H.J., Im, H.-S., Lee, C.-K., Kim, I., Kang, M.J., Hwang, J.E., Bae, W.K., Cheon, J., Park, J.O., Hong, J.Y., Kang, J.H., Kim, J.H., Lim, S.H., Kim, J.W., Kim, J.-W., Yoo, C., Choi, H.J.
Publicado 2021

Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view

por Lim, D H, Kim, D Y, Kang, M K, Kim, Y I, Kang, W K, Park, C K, Kim, S, Noh, J H, Joh, J W, Choi, S H, Sohn, T S, Heo, J S, Park, C H, Park, J O, Lee, J E, Park, Y J, Nam, H R, Park, W, Ahn, Y C, Huh, S J
Publicado 2004

Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients

por Kim, S T, Banks, K C, Pectasides, E, Kim, S Y, Kim, K, Lanman, R B, Talasaz, A, An, J, Choi, M G, Lee, J H, Sohn, T S, Bae, J M, Kim, S, Park, S H, Park, J O, Park, Y S, Lim, H Y, Kim, N K D, Park, W, Lee, H, Bass, A J, Kim, K, Kang, W K, Lee, J
Publicado 2018